[To learn English]
Medical device maker Dexcom said the use of its continuous glucose monitor, G7, led to improved blood sugar control in patients with type 2 diabetes not using insulin, compared with routine care, according to study results.
The 26-week study tested 283 non-insulin using diabetic patients, of whom half were put on Dexcom’s G7 and half used self-monitoring of blood glucose. Most participants were on common diabetes medication such as metformin, GLP-1s and SGLT2s.
医疗器械制造商德康医疗表示，研究结果显示，使用其连续血糖监测仪G7，可改善非胰岛素治疗的2型糖尿病患者的血糖控制水平，优于常规护理。
这项为期26周的研究测试了283名非胰岛素治疗的糖尿病患者，其中一半使用德康G7，另一半采用自我血糖监测。大多数参与者正在服用常见糖尿病药物，如二甲双胍、GLP-1类和SGLT2类。
LearnEnglish Leave a remark